Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06322212 · ClinicalTrials.gov registry record · Early Phase 1
Type 2 Diabetes and Blood Brain Barrier Improvement
A Early Phase 1 study of Type2diabetes, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 52
- Enrollment target
- 1
- Study location
NCT06322212 is a Early Phase 1 study of Type2diabetes that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 52 participants, below the 492-participant average among 19 other Type2diabetes trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06322212, a Early Phase 1 study of Type2diabetes, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 52 participants
- Enrollment target
- 1
- Study location
Study Summary
The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsules) can improve function. Patients will be asked to come to UCLA two times three months apart and each visit will last about 2.5-3 hours.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Thiamine
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2027-03-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06322212
The ClinicalTrials.gov registry entry for NCT06322212 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 492-participant average among 19 other Type2diabetes trials with a reported enrollment target (89% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type2diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06322212 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06322212 about?
NCT06322212 is a clinical study titled "Type 2 Diabetes and Blood Brain Barrier Improvement". The majority of T2DM adults show thiamine (vitamin B1) deficiency which may contribute to impaired function. This study will examine patients with T2DM through brain MRI scans, cognition assessments, blood tests, and questionnaires. Our goal is to see if a thiamine treatment (taking vitamin B1 capsu...
What is the current status of trial NCT06322212?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 52 participants. The study started on 2024-08-01. Estimated completion is 2027-03-31.
What conditions does trial NCT06322212 study?
This clinical trial studies the following conditions: Type2diabetes.
What interventions are being tested in trial NCT06322212?
The interventions under investigation include: Placebo (OTHER), Thiamine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06322212?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06322212 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type2diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketones, SGLT2, HFrEF
RECRUITING · Early Phase 1
-
Fiber Supplementation in Heart Failure With Preserved Ejection Fraction (HFpEF)
RECRUITING · NA
-
Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching
RECRUITING · NA
-
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
RECRUITING · NA
-
NAD Augmentation in Diabetes Kidney Disease
RECRUITING · Phase 2
-
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.